•The administration benefit is only valid for patients with commercial (private) insurance coverage or where the patient does not have insurance coverage at all. Administration benefit eligibility includes patients who are uninsured/underinsured or who are not using their Medicare A benefit
•Patients outofpocket costs up to $550 for the 150mg starting dose then up to $350 per infusion every infusion thereafter; patients are responsible for any costs that exceed the program’s maximum benefits